activity
20162026
most citedImage biomarker standardisation initiative

4.2k citations · 11.8k across the 61 of their papers we have counts for

collaborators

63 papers

cs.CV2026

The Federated Tumor Segmentation and Classification (FeTS++) Challenge

Wenyi Tang, Carla Pitarch-Abaigar, Siddhesh Thakur +5

International challenges have become the standard for developing and benchmarking biomedical image analysis methods using centralized multi-institutional data. Federated learning (…

cs.CV2026

Benchmarking Vision-Language Models for Automated Pathology Diagnosis and Report Generation

Yumi Lee, Harim Oh, Hyoryung Kim +52

The rapid advancement of vision-language models (VLMs) has accelerated progress in computational pathology; however, whole-slide image (WSI)-based pathology report generation remai…

cs.AI2026

Explainable Artificial Intelligence (XAI) in Computational Pathology: Definitions, Taxonomy, and Recommendations

Shubham Innani, Suhang You, Adam Shephard +13

Computational pathology (CompPath) is transforming medicine by leveraging artificial intelligence (AI) algorithms to support diagnosis, prognosis, and treatment prediction from gig…

cs.CV2025★ 4 cited

The MICCAI Federated Tumor Segmentation (FeTS) Challenge 2024: Efficient and Robust Aggregation Methods for Federated Learning

Akis Linardos, Sarthak Pati, Ujjwal Baid +25

We present the design and results of the MICCAI Federated Tumor Segmentation (FeTS) Challenge 2024, which focuses on federated learning (FL) for glioma sub-region segmentation in m…

cs.CV2025★ 1 cited

Medical Imaging AI Competitions Lack Fairness

Annika Reinke, Evangelia Christodoulou, Sthuthi Sadananda +34

Benchmarking competitions are central to the development of artificial intelligence (AI) in medical imaging, defining performance standards and shaping methodological progress. How…

cs.CV2025

Classifying Histopathologic Glioblastoma Sub-regions with EfficientNet

Sanyukta Adap, Ujjwal Baid, Spyridon Bakas

Glioblastoma (GBM) is the most common aggressive, fast-growing brain tumor, with a grim prognosis. Despite clinical diagnostic advancements, there have not been any substantial imp…